| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author Index
|
|
|
2013
|
45 |
S1 |
p. S49-S54
6 p.
|
artikel
|
| 2 |
Editorial Board
|
|
|
2013
|
45 |
S1 |
p. i-
1 p.
|
artikel
|
| 3 |
F-16 A cohort study of chronic hepatitis type B: progression to cirrhosis and mortality during 25 years follow-up
|
Ieluzzi, D.
|
|
2013
|
45 |
S1 |
p. S35-S36
2 p.
|
artikel
|
| 4 |
F-24 Acoustic radiation force impluse (ARFI) vs. Fibroscan (FS) in detection of severe fibrosis in ortotopic liver transplant: preliminary results
|
De Santis, A.
|
|
2013
|
45 |
S1 |
p. S38-
1 p.
|
artikel
|
| 5 |
F-03 Age and gender influence the achievement of SVR in chronic hepatitis C patients carrying favourable interleukin 28-B genotypes
|
Dissegna, D.
|
|
2013
|
45 |
S1 |
p. S32-
1 p.
|
artikel
|
| 6 |
F-35 Alpha2-adrenergic receptor agonists, added to traditional diuretics, result in effective treatment of refractory ascites in rat liver cirrhosis
|
Sansoè, G.
|
|
2013
|
45 |
S1 |
p. S41-S42
2 p.
|
artikel
|
| 7 |
F-39 Alpha-fetoprotein changes as surveillance test for hepatocellular carcinoma: results of a case-control study
|
Frigerio, M.
|
|
2013
|
45 |
S1 |
p. S43-
1 p.
|
artikel
|
| 8 |
F-18 ALT levels are associated with metabolic parameters and age in a large real-life population
|
Vespasiani Gentilucci, U.
|
|
2013
|
45 |
S1 |
p. S36-
1 p.
|
artikel
|
| 9 |
F-46 A novel model of priority assessment for patients with and without hepatocellular carcinoma on a common liver transplant waiting list: a multicentre, cohort study
|
Vitale, A.
|
|
2013
|
45 |
S1 |
p. S45-
1 p.
|
artikel
|
| 10 |
F-01 Baseline and early dynamic evaluation of HCV NS3-resistance
|
Di Paolo, D.
|
|
2013
|
45 |
S1 |
p. S31-
1 p.
|
artikel
|
| 11 |
F-51 Berberine ameliorates hepatic injury in mice acting on the NALP3 inflammasome pathway
|
Vivoli, E.
|
|
2013
|
45 |
S1 |
p. S46-
1 p.
|
artikel
|
| 12 |
F-52 Cell marker identification in cancer stem cells (CSCs) of hepatocellular carcinoma (HCC)
|
Colombo, F.
|
|
2013
|
45 |
S1 |
p. S47-
1 p.
|
artikel
|
| 13 |
F-38 Chubby is beautiful: subcutaneous fat area as predictor of better survival in patients with HCC treated with sorafenib
|
De Santis, A.
|
|
2013
|
45 |
S1 |
p. S42-
1 p.
|
artikel
|
| 14 |
F-32 Clinical impact of A/H1/N1/09 influenza in patients with cirrhosis: experience from a nosocomial cluster of infection
|
Marzano, A.
|
|
2013
|
45 |
S1 |
p. S40-
1 p.
|
artikel
|
| 15 |
F-05 Clinical implications of baseline population sequencing of the NS3 protease in HCV-1 partial or null-responders to Peg-interferon/ribavirin
|
Galmozzi, E.
|
|
2013
|
45 |
S1 |
p. S32-
1 p.
|
artikel
|
| 16 |
F-19 Correlation between ultrasonographic Hamaguchi score, insulin resistance, obesity and fatty liver indexes in patients affected by NAFLD
|
Delle Monache, M.
|
|
2013
|
45 |
S1 |
p. S36-S37
2 p.
|
artikel
|
| 17 |
F-43 Demographic, clinical and biochemical characteristics of hepatocellular carcinoma in southern Italy
|
De Luca, M.
|
|
2013
|
45 |
S1 |
p. S44-
1 p.
|
artikel
|
| 18 |
F-07 Differential effect of pegylated interferon alpha 2a and alpha 2b on the early hepatitis C virus kinetics
|
Durante-Mangoni, E.
|
|
2013
|
45 |
S1 |
p. S33-
1 p.
|
artikel
|
| 19 |
F-47 Early introduction of everolimus in de novo liver transplantation: a multicenter randomized clinical trial (EPOCAL)
|
Cillo, U.
|
|
2013
|
45 |
S1 |
p. S45-
1 p.
|
artikel
|
| 20 |
F-29 Endothelial dysfunction in cirrhosis and its relationship with portal hypertension and liver failure
|
Garcovich, M.
|
|
2013
|
45 |
S1 |
p. S39-S40
2 p.
|
artikel
|
| 21 |
F-34 Epidemiology of venous thrombotic events and pulmonary embolism among hospitalized cirrhotic patients: a single center experience
|
Ponziani, F.R.
|
|
2013
|
45 |
S1 |
p. S41-
1 p.
|
artikel
|
| 22 |
F-56 Evaluation of efficacy of antiangiogenic treatment in a murine model of hepatocellular carcinoma under different treatment schedules
|
Salvatore, V.
|
|
2013
|
45 |
S1 |
p. S48-
1 p.
|
artikel
|
| 23 |
F-28 Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis
|
Marcacci, M.
|
|
2013
|
45 |
S1 |
p. S39-
1 p.
|
artikel
|
| 24 |
F-14 Hypophosphatemia in Caucasian HBV patients treated with tenofovir is influenced by previous adefovir treatement
|
Marietti, M.
|
|
2013
|
45 |
S1 |
p. S35-
1 p.
|
artikel
|
| 25 |
F-12 IL28B genotype in patients with chronic hepatitis delta (HDV) correlates with unfavourable outcome but not with response to IFN treatment
|
Romeo, R.
|
|
2013
|
45 |
S1 |
p. S34-S35
2 p.
|
artikel
|
| 26 |
F-08 IL28B genotype is not associated with insulin resistance in chronic hepatitis C patients
|
Degasperi, E.
|
|
2013
|
45 |
S1 |
p. S33-
1 p.
|
artikel
|
| 27 |
F-44 Improving prognosis of HCC in the real-world clinical practice: an Italian field experience
|
Borzio, M.
|
|
2013
|
45 |
S1 |
p. S44-
1 p.
|
artikel
|
| 28 |
F-02 Incidence and consequences of thrombocytopenia in 1523 HIV/HCV coinfected patients treated with PEGylated interferon and ribavirin
|
Cattelan, A.M.
|
|
2013
|
45 |
S1 |
p. S31-S32
2 p.
|
artikel
|
| 29 |
F-04 Incidence, predictors and management strategies of anemia in HIV/HCV coinfected patients treated with PEGylated interferon and ribavirin
|
Angeli, E.
|
|
2013
|
45 |
S1 |
p. S32-
1 p.
|
artikel
|
| 30 |
F-06 Industrial, but not fruit fructose intake is independently associated with severe liver fibrosis in genotype 1 chronic hepatitis C patients
|
Petta, S.
|
|
2013
|
45 |
S1 |
p. S33-
1 p.
|
artikel
|
| 31 |
F-53 In hepatocellular carcinoma miR-494 is regulated by epigenetic mechanisms and targets p27, PTEN and PUMA
|
Fornari, F.
|
|
2013
|
45 |
S1 |
p. S47-
1 p.
|
artikel
|
| 32 |
F-49 International benchmarking in liver transplantation in Europe
|
Carbone, M.
|
|
2013
|
45 |
S1 |
p. S46-
1 p.
|
artikel
|
| 33 |
F-23 Leukaemia inhibitory factor protects cholangiocytes from cytotoxicity in cholangiocarcinoma
|
Morton, S.D.
|
|
2013
|
45 |
S1 |
p. S38-
1 p.
|
artikel
|
| 34 |
F-42 Liver perfusion CT for non-invasive assessment of response to sorafenib therapy in patients with advanced HCC: preliminary findings
|
Sacco, R.
|
|
2013
|
45 |
S1 |
p. S43-S44
2 p.
|
artikel
|
| 35 |
F-30 Liver stiffness measurement (LSM) predicts the decompensation and the liver related death in patients with compensated HCV cirrhosis
|
Calvaruso, V.
|
|
2013
|
45 |
S1 |
p. S40-
1 p.
|
artikel
|
| 36 |
F-26 Liver stiffness values in healthy subjects without evidence of liver disease performed in an adult community-based population
|
Conti, F.
|
|
2013
|
45 |
S1 |
p. S38-S39
2 p.
|
artikel
|
| 37 |
F-48 Liver transplantation for HBV-related liver disease: the experience of Padua Liver Transplant Center
|
Bortoluzzi, I.
|
|
2013
|
45 |
S1 |
p. S45-S46
2 p.
|
artikel
|
| 38 |
F-22 Metabolic alterations of lipid kinetics in NAFLD patients and their contribution to liver damage
|
Rosso, C.
|
|
2013
|
45 |
S1 |
p. S37-
1 p.
|
artikel
|
| 39 |
F-45 Neoangiogenesis after TACE: any difference between conventional and DC-Beads-mediated transarterial chemoembolization?
|
Castelli, G.
|
|
2013
|
45 |
S1 |
p. S44-S45
2 p.
|
artikel
|
| 40 |
F-50 Obstructive cholestasis induces a lobe-specific matrix metalloproteinase activation in rat livers
|
Palladini, G.
|
|
2013
|
45 |
S1 |
p. S46-
1 p.
|
artikel
|
| 41 |
F-21 PNPLA3 I148M gene variant is not associated with metabolic syndrome and cardiometabolic risk in non-alcoholic fatty liver disease
|
Del Ben, M.
|
|
2013
|
45 |
S1 |
p. S37-
1 p.
|
artikel
|
| 42 |
F-31 Prediction of in-hospital mortality of patients with cirrhosis by acute renal failure. Comparison of akin and conventional criteria
|
Severgnini, L.
|
|
2013
|
45 |
S1 |
p. S40-
1 p.
|
artikel
|
| 43 |
F-33 Predictors of response to anticoagulant therapy for the treatment of portal vein thrombosis (PVT) in cirrhosis patients
|
Rodriguez, K.I.
|
|
2013
|
45 |
S1 |
p. S41-
1 p.
|
artikel
|
| 44 |
F-09 Prevalence and therapy of lymphoproliferative disorders in hepatitis C chronic infection: a study of 440 cases
|
Mazzaro, C.
|
|
2013
|
45 |
S1 |
p. S33-S34
2 p.
|
artikel
|
| 45 |
F-15 Regression of cirrhosis by hepatic venous pressure gradient (HVPG) measurement in long-term responders to anti-HBV therapy
|
Marengo, A.
|
|
2013
|
45 |
S1 |
p. S35-
1 p.
|
artikel
|
| 46 |
F-20 Risk of obstructive sleep apnea syndrome and association with liver damage in patients with nonalcoholic fatty liver disease without severe obesity
|
Pulixi, E.A.
|
|
2013
|
45 |
S1 |
p. S37-
1 p.
|
artikel
|
| 47 |
F-11 Serological characterization of occult HBV infection in liver donors
|
Caviglia, G.P.
|
|
2013
|
45 |
S1 |
p. S34-
1 p.
|
artikel
|
| 48 |
F-55 SERPINB3 increases resistance to chemotherapeutic agents inhibiting ROS production and the permeability transition pore
|
Ciscato, F.
|
|
2013
|
45 |
S1 |
p. S47-S48
2 p.
|
artikel
|
| 49 |
F-54 SERPIN-B3 induces HIF2α nuclear translocation in hepatic cancer cells: a paracrine loop able to affect cancer cell behaviour
|
Cannito, S.
|
|
2013
|
45 |
S1 |
p. S47-
1 p.
|
artikel
|
| 50 |
F-17 Serum HBsAg decline is faster than previously estimated in long-term NUC responders with low treatment-induced HBsAg levels
|
Mangia, G.
|
|
2013
|
45 |
S1 |
p. S36-
1 p.
|
artikel
|
| 51 |
F-41 Sorafenib for hepatocellular carcinoma (HCC) in patients with established cirrhosis: impact of the type of recruiting unit and predictors of survival
|
Inghilesi, A.
|
|
2013
|
45 |
S1 |
p. S43-
1 p.
|
artikel
|
| 52 |
F-37 Sorafenib versus 90Y-radioembolization: a preliminary study on tolerability and survival in patients with advanced mono-lobar hepatocellular carcinoma
|
Gaia, S.
|
|
2013
|
45 |
S1 |
p. S42-
1 p.
|
artikel
|
| 53 |
F-13 Switching to tenofovir is safe in most CHB patients with a reduced glomerular filtration rate due to previous exposure to adefovir dipivoxil
|
Viganò, M.
|
|
2013
|
45 |
S1 |
p. S35-
1 p.
|
artikel
|
| 54 |
F-40 The impact of baseline characteristics on the survival in a cohort of 270 patients with hepatocellular carcinoma treated with transarterial chemoembolization: a single center study
|
Biolato, M.
|
|
2013
|
45 |
S1 |
p. S43-
1 p.
|
artikel
|
| 55 |
F-27 The inflammasome complex is a target of the HIV envelope protein gp120 in human hepatic stellate cells (HSC) and mononuclear cells (MNC)
|
Cappon, A.
|
|
2013
|
45 |
S1 |
p. S39-
1 p.
|
artikel
|
| 56 |
F-25 The prognostic role of magnetic resonance cholangiography in primary sclerosing cholangitis (PSC)
|
Franceschet, I.
|
|
2013
|
45 |
S1 |
p. S38-
1 p.
|
artikel
|
| 57 |
F-36 Transarterial chemoembolization with drug-eluting beads (DEB TACE) for BCLC-A hepatocellular carcinoma (HCC): a radical option?
|
Manini, M.A.
|
|
2013
|
45 |
S1 |
p. S42-
1 p.
|
artikel
|
| 58 |
F-10 Treatment outcomes and predictors of response in treatment-naive hepatitis C patients treated with Peg-interferon alpha/ribavirin in real-world Italian clinics: PROPHESYS sub-analysis
|
Ascione, A.
|
|
2013
|
45 |
S1 |
p. S34-
1 p.
|
artikel
|
| 59 |
OC-04 Activation of the mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma
|
Di Maira, G.
|
|
2013
|
45 |
S1 |
p. S2-
1 p.
|
artikel
|
| 60 |
OC-27 An open, randomized, multicentre trial to evaluate efficacy and safety of a 24 week-course of Peg-interferon α-2b versus a 12 week-course of Peg-Interferon α-2b alone or plus ribavirin in patients with acute hepatitis C
|
Santantonio, T.
|
|
2013
|
45 |
S1 |
p. S9-S10
2 p.
|
artikel
|
| 61 |
OC-29 Antiviral activity of flavonoid-derived compounds against hepatitis B virus
|
Pollicino, T.
|
|
2013
|
45 |
S1 |
p. S10-
1 p.
|
artikel
|
| 62 |
OC-25 Bio-mathematical modelling provides the most accurate selection of HCV-G1 patients for triple-therapy
|
Colombatto, P.
|
|
2013
|
45 |
S1 |
p. S9-
1 p.
|
artikel
|
| 63 |
OC-28 Boceprevir triple therapy in patients with mixed cryoglobulinemia
|
Triboli, E.
|
|
2013
|
45 |
S1 |
p. S10-
1 p.
|
artikel
|
| 64 |
OC-15 Clinical validation of a sub-staging proposal of patients with intermediate HCC (BCLC-B)
|
Pecorelli, A.
|
|
2013
|
45 |
S1 |
p. S5-S6
2 p.
|
artikel
|
| 65 |
OC-09 Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients
|
Mezzabotta, L.
|
|
2013
|
45 |
S1 |
p. S3-S4
2 p.
|
artikel
|
| 66 |
OC-01 CXCL1 and CXCL10 secretion by Fibrocistin-defective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis
|
Locatelli, L.
|
|
2013
|
45 |
S1 |
p. S1-
1 p.
|
artikel
|
| 67 |
OC-05 Differentiation of human pluripotent stem cells into hepatic cells and development of a liver tissue on a chip
|
Giobbe, G.G.
|
|
2013
|
45 |
S1 |
p. S2-
1 p.
|
artikel
|
| 68 |
OC-19 Donor/recipient seven gene signature (cirrhosis risk score) and donor age as predictors of liver fibrosis progression due to hepatitis C recurrence after liver transplantation
|
Lenisa, I.
|
|
2013
|
45 |
S1 |
p. S7-
1 p.
|
artikel
|
| 69 |
OC-08 Dysbiosis contributes to liver fibrosis through bacterial translocation and elevated endotoxemia by increasing Gram– abundance
|
De Minicis, S.
|
|
2013
|
45 |
S1 |
p. S3-
1 p.
|
artikel
|
| 70 |
OC-24 Genotype analysis, at baseline and early time-points, by population and ultra-deep sequencing in HCV patients treated with BOC/TVR-based therapy
|
Di Maio, V.C.
|
|
2013
|
45 |
S1 |
p. S8-S9
2 p.
|
artikel
|
| 71 |
OC-10 Hepatocyte-derived microparticles released in blood as biomarkers of NASH development
|
Povero, D.
|
|
2013
|
45 |
S1 |
p. S4-
1 p.
|
artikel
|
| 72 |
OC-30 Incidence and clinical consequences of reduced tubular phosphate re-absorption in naïve CHB patients treated with tenofovir: a two-year field study
|
Viganò, M.
|
|
2013
|
45 |
S1 |
p. S10-S11
2 p.
|
artikel
|
| 73 |
OC-18 Liver transplantation in cirrhotic patients with MELD score <18: a new model to predict drop-out from the waiting list
|
Dall'Agata, M.
|
|
2013
|
45 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 74 |
OC-34 OPERA: the use of Pegylated interferon and ribavirin for the treatment of HCV/HIV coinfection in interferon-naïve patients in Italy
|
Carosi, G.
|
|
2013
|
45 |
S1 |
p. S12-
1 p.
|
artikel
|
| 75 |
OC-12 P53 and hepatic lipid metabolism: a new interesting connection
|
Gori, M.
|
|
2013
|
45 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 76 |
OC-11 PNPLA3 GG genotype is associated with carotid atherosclerosis in patients with non-alcoholic fatty liver disease
|
Petta, S.
|
|
2013
|
45 |
S1 |
p. S4-
1 p.
|
artikel
|
| 77 |
OC-17 Portopulmonary hypertension treatment in orthotopic liver transplantation era
|
Risso, A.
|
|
2013
|
45 |
S1 |
p. S6-
1 p.
|
artikel
|
| 78 |
OC-35 Post-transcriptional changes of serum albumin and its relationship with clinical features and prognosis in cirrhotic patients
|
Domenicali, M.
|
|
2013
|
45 |
S1 |
p. S12-
1 p.
|
artikel
|
| 79 |
OC-07 Primary biliary cirrhosis and metabolic syndrome
|
Cazzagon, N.
|
|
2013
|
45 |
S1 |
p. S3-
1 p.
|
artikel
|
| 80 |
OC-20 Prophylaxis of hepatitis B after liver transplantation: report of an Italian survey in a cohort of 2260 patients
|
Fasulo, R.
|
|
2013
|
45 |
S1 |
p. S7-
1 p.
|
artikel
|
| 81 |
OC-06 Rac1 and Cdc42 activation regulates PDGF-D-mediated CAF recruitment by cancer cells in cholangiocarcinoma
|
Cadamuro, M.
|
|
2013
|
45 |
S1 |
p. S2-S3
2 p.
|
artikel
|
| 82 |
OC-13 Radiofrequency ablation versus hepatic resection for early hepatocellular carcinoma: a cost-effectiveness perspective
|
Cucchetti, A.
|
|
2013
|
45 |
S1 |
p. S5-
1 p.
|
artikel
|
| 83 |
OC-14 Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma: a randomized controlled trial
|
Di Costanzo, G.G.
|
|
2013
|
45 |
S1 |
p. S5-
1 p.
|
artikel
|
| 84 |
OC-16 Resectable hepatocellular carcinoma is a contraindication to liver transplant: a novel decision model based on “number needed to transplant” as measure of transplant benefit
|
Vitale, A.
|
|
2013
|
45 |
S1 |
p. S6-
1 p.
|
artikel
|
| 85 |
OC-23 Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia
|
Fognani, E.
|
|
2013
|
45 |
S1 |
p. S8-
1 p.
|
artikel
|
| 86 |
OC-03 SERPIN-B3 as a pro-fibrogenic mediator contributing to chronic liver disease progression
|
Paternostro, C.
|
|
2013
|
45 |
S1 |
p. S2-
1 p.
|
artikel
|
| 87 |
OC-02 Shotgun proteomics identifies specific protein profiles in apoptotic bodies from biliary epithelial cells
|
Lleo, A.
|
|
2013
|
45 |
S1 |
p. S1-
1 p.
|
artikel
|
| 88 |
OC-33 Spleen and liver stiffness measurement can predict clinical complications in compensated cirrhotic patients: a prospective study
|
Colecchia, A.
|
|
2013
|
45 |
S1 |
p. S11-S12
2 p.
|
artikel
|
| 89 |
OC-22 Suppression of HBV transcription and replication by small molecules that target the epigenetic control of nuclear cccDNA minichromosome
|
Palumbo, G.A.
|
|
2013
|
45 |
S1 |
p. S8-
1 p.
|
artikel
|
| 90 |
OC-21 The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent
|
D'Ambrosio, R.
|
|
2013
|
45 |
S1 |
p. S8-
1 p.
|
artikel
|
| 91 |
OC-32 The changing face of chronic HBV infection. The Italian Master-B cohort
|
Brancaccio, G.
|
|
2013
|
45 |
S1 |
p. S11-
1 p.
|
artikel
|
| 92 |
OC-31 The outcome of chronic hepatitis D is predicted by the levels of HDV viremia
|
Romeo, R.
|
|
2013
|
45 |
S1 |
p. S11-
1 p.
|
artikel
|
| 93 |
OC-26 Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the Italian telaprevir early access program
|
Colombo, M.
|
|
2013
|
45 |
S1 |
p. S9-
1 p.
|
artikel
|
| 94 |
T-41 Accuracy of [18F]fluorocholine (18F-FCH) PET/CT for the characterization of de novo liver nodules detected in cirrhotic patients: aprospective pilot study
|
Manini, M.A.
|
|
2013
|
45 |
S1 |
p. S26-
1 p.
|
artikel
|
| 95 |
T-10 Acute exacerbation of chronic hepatitis C: clinical presentation, outcome and response to anti-HCV treatment
|
Sagnelli, E.
|
|
2013
|
45 |
S1 |
p. S16-
1 p.
|
artikel
|
| 96 |
T-17 Add-on Peg-IFN improves HBsAg kinetics in HBeAg-negative patients long-term fully suppressed by nucleos(t)ide analogs
|
Invernizzi, F.
|
|
2013
|
45 |
S1 |
p. S19-
1 p.
|
artikel
|
| 97 |
T-36 Antiviral therapy as secondary prophylaxis of hepatocellular carcinoma (HCC) recurrence in HCV-related cirrhosis: a case-control study
|
Di Donato, R.
|
|
2013
|
45 |
S1 |
p. S25-
1 p.
|
artikel
|
| 98 |
T-03 Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients
|
Petta, S.
|
|
2013
|
45 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 99 |
T-42 Can adipose tissue delay the onset of dose limiting toxicity in patients with HCC during sorafenib treatment?
|
De Santis, A.
|
|
2013
|
45 |
S1 |
p. S26-S27
2 p.
|
artikel
|
| 100 |
T-05 Cannabinoid receptor 2 (CB2) 63 QQ variant is associated with a severe histological activity index in patients with chronic hepatitis C
|
Coppola, N.
|
|
2013
|
45 |
S1 |
p. S14-
1 p.
|
artikel
|
| 101 |
T-22 Carotid intima-media thickness, endothelial lipase and hepatic lipase are altered in subjects with non alcoholic fatty liver disease (NAFLD)
|
Del Forno, A.
|
|
2013
|
45 |
S1 |
p. S20-
1 p.
|
artikel
|
| 102 |
T-02 Chronic HCV infection and extrahepatic diseases: ischemic stroke and ischemic heart disease
|
Restivo, L.
|
|
2013
|
45 |
S1 |
p. S13-
1 p.
|
artikel
|
| 103 |
T-35 Cirrhotic patients fail to regain muscle mass after liver transplantation
|
Lattanzi, B.
|
|
2013
|
45 |
S1 |
p. S24-S25
2 p.
|
artikel
|
| 104 |
T-40 Clinical and economic impact of the updated AASLD criteria for the diagnosis of hepatocellular carcinoma (HCC)
|
Manini, M.A.
|
|
2013
|
45 |
S1 |
p. S26-
1 p.
|
artikel
|
| 105 |
T-09 Correlation between NS5A variants and fibrosis progression in patients with HCV recurrence after liver transplantation
|
Lenci, I.
|
|
2013
|
45 |
S1 |
p. S15-S16
2 p.
|
artikel
|
| 106 |
T-32 Cost-effectiveness of a new model of specialistic caregiving for outpatients with cirrhosis and ascites; a prospective study
|
Morando, F.
|
|
2013
|
45 |
S1 |
p. S23-
1 p.
|
artikel
|
| 107 |
T-46 Determinants of bleeding from esophageal varices in patients with advanced hepatocellular carcinoma treated with sorafenib
|
Iavarone, M.
|
|
2013
|
45 |
S1 |
p. S28-
1 p.
|
artikel
|
| 108 |
T-06 Early HCV-Core-Ag kinetics predict sustained virologic response in chronic hepatitis C patients treated with standard of care
|
Colombatto, P.
|
|
2013
|
45 |
S1 |
p. S14-S15
2 p.
|
artikel
|
| 109 |
T-21 Effect of iron depletion on liver damage in nonalcoholic fatty liver disease: preliminary results of a randomized controlled trial
|
Valenti, L.
|
|
2013
|
45 |
S1 |
p. S20-
1 p.
|
artikel
|
| 110 |
T-04 Effect of the IL28B single nucleotide polymorphism (SNP) on the first phase hepatitis C virus kinetics in patients treated with PEG-IFN/RBV
|
Durante-Mangoni, E.
|
|
2013
|
45 |
S1 |
p. S14-
1 p.
|
artikel
|
| 111 |
T-48 Efficacy and safety of intravenous silibinin in patients with HCV recurrence on the graft after liver transplantation (LT): a prospective, randomized, double-blind, placebo-controlled pilot study
|
Rendina, M.
|
|
2013
|
45 |
S1 |
p. S28-
1 p.
|
artikel
|
| 112 |
T-13 Entecavir (ETV) prophylaxis in inactive HBV carriers who underwent chemotherapy for solid or haematological cancer: interim analysis of a cohort study
|
Di Marco, V.
|
|
2013
|
45 |
S1 |
p. S17-
1 p.
|
artikel
|
| 113 |
T-34 Erythrocytes cell wall defects correlate with the stage of liver disease
|
Liberale, L.
|
|
2013
|
45 |
S1 |
p. S24-
1 p.
|
artikel
|
| 114 |
T-24 Fatty-HepG2 cells release molecules that lead in vitro to activation of hepatic stellate cells and epithelial-to-mesenchymal transition
|
Gnani, D.
|
|
2013
|
45 |
S1 |
p. S21-
1 p.
|
artikel
|
| 115 |
T-45 Features of patients with extrahepatic metastasis of hepatocellular carcinoma and clinical impact on survival: experience of a single Italian center
|
Fondacaro, L.M.
|
|
2013
|
45 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 116 |
T-55 Functional role of the chemokine receptor CXCR7 on CXCL12-induced chemotaxis and cell survival in cholangiocarcinoma (CCA) cells
|
Gentilini, A.
|
|
2013
|
45 |
S1 |
p. S30-S31
2 p.
|
artikel
|
| 117 |
T-44 Hepatocellular carcinoma treated with percutaneous (PEI and/or RF) ablation: absence of major complications in the experience of a single center
|
Giorgio, A.
|
|
2013
|
45 |
S1 |
p. S27-
1 p.
|
artikel
|
| 118 |
T-28 Hypothalamic-pituitary-adrenal axis and adrenal dysfunction in non-septic cirrhotic patients with ascites: a pathophysiological and clinical evaluation
|
Risso, A.
|
|
2013
|
45 |
S1 |
p. S22-
1 p.
|
artikel
|
| 119 |
T-15 Interim analysis of the Italian Master-Entas cohort study: entecavir can improve liver function in patients with chronic hepatitis B and liver cirrhosis
|
Alfieri, A.
|
|
2013
|
45 |
S1 |
p. S18-
1 p.
|
artikel
|
| 120 |
T-14 Interim analysis of the Italian Master-Entas cohort study: entecavir effectiveness in field practice for chronic hepatitis B
|
Giuberti, T.
|
|
2013
|
45 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 121 |
T-08 Interplay between on-treatment predictors and donor/recipients IL28B in predicting SVR to pegIFN/ribavirin in HCV-1,4 liver transplant recipients
|
Donato, M.F.
|
|
2013
|
45 |
S1 |
p. S15-
1 p.
|
artikel
|
| 122 |
T-16 Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression
|
Coppola, N.
|
|
2013
|
45 |
S1 |
p. S18-
1 p.
|
artikel
|
| 123 |
T-25 MC2791, a specific class III HDAC Sirt1 agonist drug, decreases lipids and reactive oxygen species accumulation in an in vitro model of steatosis in differentiated HepaRG cells
|
Pediconi, N.
|
|
2013
|
45 |
S1 |
p. S21-
1 p.
|
artikel
|
| 124 |
T-53 Mechanic-based reprogramming of hepatic self-renewing tumor-initiating cells through DNMT1-inhibition
|
Raggi, C.
|
|
2013
|
45 |
S1 |
p. S30-
1 p.
|
artikel
|
| 125 |
T-30 Mortality for chronic liver disease and hepatocellular carcinoma in Italy and Europe over the last 40 years
|
Ascione, A.
|
|
2013
|
45 |
S1 |
p. S23-
1 p.
|
artikel
|
| 126 |
T-37 Mortality prediction with transient elastography in recurrent-HCV infection after liver transplantation
|
Pecorelli, A.
|
|
2013
|
45 |
S1 |
p. S25-
1 p.
|
artikel
|
| 127 |
T-23 NAFLD and cardiovascular disease: may a suffering liver be a marker of cardiovascular risk?
|
Viscomi, C.
|
|
2013
|
45 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 128 |
T-01 OPTIMIZE trial: non-inferiority of twice-daily telaprevir versus administration every 8 hours in treatment-naïve, genotype 1 HCV infected patients
|
Rizzetto, M.
|
|
2013
|
45 |
S1 |
p. S13-
1 p.
|
artikel
|
| 129 |
T-56 Oxidative genomic and mitochondrial damage in relation to telomeric dysfunction in liver carinogenesis
|
Piciocchi, M.
|
|
2013
|
45 |
S1 |
p. S31-
1 p.
|
artikel
|
| 130 |
T-50 Patients/doctors/nurses relationship after liver transplantation: a prospective study on patient's satisfaction
|
De Placido, M.
|
|
2013
|
45 |
S1 |
p. S29-
1 p.
|
artikel
|
| 131 |
T-20 Performance of controlled attenuation parameter (CAP) in assessing liver steatosis
|
Ferraioli, G.
|
|
2013
|
45 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 132 |
T-47 Poor predictive ability of the American Donor Risk Index in orthotopic liver transplantation in Europe
|
Carbone, M.
|
|
2013
|
45 |
S1 |
p. S28-
1 p.
|
artikel
|
| 133 |
T-19 Reproducibility of controlled attenuation parameter (CAP) for the assessment of liver steatosis
|
Ferraioli, G.
|
|
2013
|
45 |
S1 |
p. S19-
1 p.
|
artikel
|
| 134 |
T-07 rs4374383 polymorphism of MERTK gene influences the progression of liver fibrosis in thalassemia major patients with chronic hepatitis C
|
Calvaruso, V.
|
|
2013
|
45 |
S1 |
p. S15-
1 p.
|
artikel
|
| 135 |
T-54 SerpinB3 drives molecular signatures of worse prognosis and is associated with tumor recurrence in hepatocellular carcinoma
|
Turato, C.
|
|
2013
|
45 |
S1 |
p. S30-
1 p.
|
artikel
|
| 136 |
T-29 Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis
|
Fiorini, M.
|
|
2013
|
45 |
S1 |
p. S22-S23
2 p.
|
artikel
|
| 137 |
T-39 Small nodules arising in cirrhotic liver during surveillance: possibility of characterization among dysplastic nodule, early hepatocellular carcinoma and progressed hepatocellular carcinoma using CEUS
|
Giorgio, A.
|
|
2013
|
45 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 138 |
T-51 Study of HBV (re)infection in the course of liver transplantation in HBV, HBV/HDV and occult HBV infected patients
|
Pollicino, T.
|
|
2013
|
45 |
S1 |
p. S29-
1 p.
|
artikel
|
| 139 |
T-27 Study of new algorithms for non-invasive staging of liver fibrosis in chronic viral hepatitis (CH) and non-alcoholic fatty liver disease (NAFLD)
|
Campion, D.
|
|
2013
|
45 |
S1 |
p. S22-
1 p.
|
artikel
|
| 140 |
T-38 Survival of patients with hepatocellular carcinoma (HCC) is affected by complete response to radio-frequency thermal ablation (RFTA)
|
Cabibbo, G.
|
|
2013
|
45 |
S1 |
p. S25-
1 p.
|
artikel
|
| 141 |
T-31 Sustained virological response to PEG IFN plus RBV reduces the risk of disease decompensation and HCC in patients with HCV cirrhosis
|
Calvaruso, V.
|
|
2013
|
45 |
S1 |
p. S23-
1 p.
|
artikel
|
| 142 |
T-12 Tenofovir suppressed viral suppression in most field practice, treatment-naïve patients with CHB followed for 3 years in a multicenter European study
|
Lampertico, P.
|
|
2013
|
45 |
S1 |
p. S16-S17
2 p.
|
artikel
|
| 143 |
T-18 The HBV capsid inhibitors HAPs affect core protein interaction with the minichromosome and target cccDNA function
|
Belloni, L.
|
|
2013
|
45 |
S1 |
p. S19-
1 p.
|
artikel
|
| 144 |
T-26 The myostatin system is expressed in the liver and its activation mediates profibrogenic actions via c-Jun N-terminal kinase
|
Caligiuri, A.
|
|
2013
|
45 |
S1 |
p. S21-S22
2 p.
|
artikel
|
| 145 |
T-52 The role of immunity and gender during acute liver injury
|
Di Liddo, R.
|
|
2013
|
45 |
S1 |
p. S29-S30
2 p.
|
artikel
|
| 146 |
T-33 The triangular relationship between leaky-gut, microbiota and spontaneous bacterial peritonitis in liver cirrhotic patients
|
Ponziani, F.R.
|
|
2013
|
45 |
S1 |
p. S24-
1 p.
|
artikel
|
| 147 |
T-49 Transient elastography has a practical role in monitoring liver-transplanted patients: preliminary results from experience in a real world setting
|
Rinaldi, L.
|
|
2013
|
45 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 148 |
T-43 Treatment of single-nodule hepatocarcinoma: comparison between surgical resection and transarterial chemoembolization combined with radiofrequency
|
Cesario, V.
|
|
2013
|
45 |
S1 |
p. S27-
1 p.
|
artikel
|
| 149 |
T-11 5-year entecavir in NUC-naïve, field-practice patients with CHB showed excellent viral suppression and safety but no prevention of HCC
|
Lampertico, P.
|
|
2013
|
45 |
S1 |
p. S16-
1 p.
|
artikel
|
Tijdschrift beschrijving